Backed by Philadelphia investment firm, life sciences startup launches with $169M


The startup launched to develop new approaches to treating immunological and inflammatory diseases.

Previous Compassion, culture important in creating healthy workplace, local executives say
Next Exclusive: Tampa General teams up with Colorado tech company, expects to double AI department in the next year